GSK plc (LON:GSK) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Shares of GSK plc (LON:GSK) have received an average recommendation of “Moderate Buy” from the seven analysts that are presently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and five have issued a buy rating on the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is GBX 1,791.25 ($22.72).

GSK has been the topic of several recent research reports. Barclays reaffirmed an “equal weight” rating and set a GBX 1,725 ($21.88) price objective on shares of GSK in a report on Tuesday, May 7th. JPMorgan Chase & Co. reissued an “underweight” rating on shares of GSK in a report on Tuesday, June 18th. Citigroup reissued a “buy” rating and issued a GBX 2,100 ($26.64) price target on shares of GSK in a report on Monday. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a GBX 1,950 ($24.74) price objective on shares of GSK in a research report on Tuesday, June 18th. Finally, Shore Capital restated a “buy” rating on shares of GSK in a research report on Thursday.

Insider Buying and Selling

In other news, insider Wendy Becker acquired 446 shares of the firm’s stock in a transaction dated Thursday, June 20th. The shares were acquired at an average cost of GBX 1,614 ($20.47) per share, with a total value of £7,198.44 ($9,131.60). 1.60% of the stock is owned by insiders.

GSK Price Performance

GSK opened at GBX 1,526 ($19.36) on Friday. The company has a market capitalization of £62.26 billion, a price-to-earnings ratio of 1,400.00, a P/E/G ratio of 1.19 and a beta of 0.27. GSK has a 1 year low of GBX 1,302.60 ($16.52) and a 1 year high of GBX 1,823.50 ($23.13). The company has a debt-to-equity ratio of 134.34, a current ratio of 0.87 and a quick ratio of 0.73. The firm’s fifty day moving average price is GBX 1,688.38 and its two-hundred day moving average price is GBX 1,629.94.

GSK Cuts Dividend

The firm also recently declared a dividend, which will be paid on Thursday, July 11th. Investors of record on Thursday, May 16th will be issued a GBX 15 ($0.19) dividend. The ex-dividend date of this dividend is Thursday, May 16th. This represents a yield of 0.9%. GSK’s dividend payout ratio is presently 5,504.59%.

GSK Company Profile

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.